Hadassah

Hadassah Doctor Receives International Prize for Medical Innovation

Tuesday, Oct 21 2014

At its 26th annual conference in Shanghai, China, the international Society for Medical Innovation and Technology (SMIT) awarded its International Prize for Medical Innovation and Technology to Prof. Yoav Mintz, Director of the Center for Innovative Surgery at the Hadassah Medical Center for his research aimed at developing a novel, nonsurgical method to perform gastric bypass and cure Type 2 diabetes. Approximately 300 participants were on hand from about 20 countries.

Prof. Mintz, in cooperation with the Israeli start-up EasyNOTES, recently developed a method to perform a gastric bypass without a single incision or anesthesia, by using an endoscope to place magnets into the small intestine and stomach. Over the next seven days following placement of the magnets, thanks to the natural healing process of the body, a connection in the tissues is formed between the magnets.

“At this point in time,” explains Prof. Mintz, “this system, in the advanced stages of development, is designed to cure Type 2 diabetes. “Two simple endoscopic procedures is all that it takes,” he adds.

There are more than 285 million cases of diabetes worldwide and a forecast of an increase to 485 million cases by the year 2030, according to the International Diabetes Federation. Gastric bypass, performed primarily for weight loss in the morbidly obese, also has the effect of putting 80 percent of cases of Type 2 diabetes into remission. As Prof. Mintz reports, global experience with bariatric surgery reveals that “patients suffering from diabetes show a resolution of their disease within a few days following surgery, even before losing weight.”

While medical centers around the world are performing gastric bypass surgery for diabetic patients who are not obese with good results, there are differing opinions as to whether the surgical risks are too great to justify the operation. Prof. Mintz’s procedure is aimed at achieving the same positive results without the risks of major invasive surgery.

Prof. Mintz is a graduate of the Hebrew University-Hadassah School of Medicine and completed his residency in surgery at the Hadassah Medical Organization. While doing a two-year fellowship at the University of California at San Diego (UCSD), Prof. Mintz worked with Prof. Mark Talmini and Prof. Santiago Horgan, world leaders in minimally invasive and robotic surgery. When he completed his fellowship, he returned to Hadassah to implement the new techniques and vision. An inventor with half a dozen patents registered in his name, Prof. Mintz serves on the steering committee of SMIT, is an active member of SAGES (Society of American Gastrointestinal and Endoscopic Surgeons), as well as EAES ( European Association of Endoscopic Surgery), where he serves on the technology committee.

Comments

From: jerry on December 12, 2015
Is anyone in the USA going this kind of endoscopy surgery as a cure of type 2 diabetes, like Dr. Mintz?
From: Myra Dunn on October 8, 2015
I am very interested in having this surgery. What is the procedure to make an appt. in Israel? Is anyone in the USA doing this procedure.
From: Adam on September 6, 2015
What do you think about this miraculous cure for type 2 diabetes?
From: Francisca on April 27, 2015
I Will be in Israel they first week of June & I Want to make an App. W/ Dr. Mitz if Possible & Also the Information about Cost of the visit with Dr. & How to pay!
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More